The NACDS and NCPA praised the United States Supreme Court's decision to hear a case involving states’ regulation of pharmacy benefit managers.
The FDA Committees voted against recommending approval of Nektar Therapeutics' oxycodegol.
Novavax’s recombinant quadrivalent flu vaccine candidate (NanoFlu) is being evaluated in an ongoing phase 3 clinical study for use in older adults.
Here are 4 pharmacy-related New Year’s resolutions that can help enhance your pharmacy services.
Shingles vaccination recommended by CDC and ADCES.
The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.
Progress has been made, but there’s still a long road ahead.
Eli Lilly added additional affordability options for patients with diabetes who use certain insulin products.
Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study.
Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.